Delivery Order SPE2DB22D3501-SPE2DB24FVJ65
Award Date
4/22/24
Potential Completion Date
4/23/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,564,663,013 units of the pharmaceutical product Atovaquone-Proguanil, in 100-count packages. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA), a defense agency. The $4,411.24 firm fixed-price delivery order is not associated with a set-aside program. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to...
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $2,927.14 for the supply of 4,566,488,958 units of atovaquone-proguanil 250-100 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 20, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $73,404 for the supply of Atovaquone-Proguanil 250-100 100s medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Atovaquone-Proguanil 250-100 medication in 100-count packages. The $9,446.27 firm fixed-price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
The federal contract award is for the delivery of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of the prime contractor Amerisourcebergen Drug Corp. The $4,343.93 firm fixed price delivery order has a completion date of September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies under an Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,449.90 firm fixed-price delivery order is for the product Atovaquone-Proguanil 250-100 100s, with an ultimate completion date of October 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Atovaquone-Proguanil 250-100 UD 24S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order worth $4,224.13, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp's Corporate Office division. The $1,163.28 firm fixed-price delivery order is for the supply of 4,565,863,722 units of the pharmaceutical product Atovaquone-Proguanil 250-100 100s. The contract has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This federal contract award is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract, valued at $6,470.71, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,032.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Atovaquone-Proguanil 250-100 UD 24S. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...